Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,680 | 2,800 | 17.04. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
Mi | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
11.04. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | 1 | HKEx | ||
07.04. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
25.03. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
21.03. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | 2 | HKEx | ||
11.03. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | - | HKEx | ||
04.03. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
19.02. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF PRELIMINARY ANNUAL RESULTS FOR THE YEAR 2024 | - | HKEx | ||
16.01. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
08.01. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
27.12.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
17.12.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
29.11.24 | HAOHAI BIOTEC (06826): ANNOUNCEMENT IN RELATION TO ADJUSTMENTS TO THE NUMBER OF RESTRICTED SHARES AND THE GRANT PRICE UNDER THE 2021 RESTRICTED A SHARE ... | - | HKEx | ||
28.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
21.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 3 | HKEx | ||
13.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
05.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
28.10.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
25.10.24 | HAOHAI BIOTEC (06826): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
25.10.24 | HAOHAI BIOTEC (06826): WORKING RULES OF THE STRATEGY AND SUSTAINABLE DEVELOPMENT COMMITTEE OF THE BOARD | 1 | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
VALNEVA | 3,050 | -0,20 % | Valneva: Fast sensationell! | News von Trading-Treff.de Valneva hat einen hohen Verlust hinnehmen müssen. Die Aktie verlor gestern am Markt 6,66 %. Damit ist der Titel auch noch (teils) für sehr kurze Zeit unter die Marke von drei... ► Artikel lesen | |
AMGEN | 243,65 | -0,06 % | Amgen-Aktie: Kurs fällt ab (237,5811 €) | Das Wertpapier von Amgen notiert heute ein wenig leichter. Die Aktie notiert derzeit bei 269,98 US-Dollar. Für die Amgen-Aktie steht gegenwärtig ein Abschlag von 4,48 Prozent zu Buche. Das Wertpapier... ► Artikel lesen | |
STRYKER | 306,10 | +0,39 % | Stryker Aktie: Leichte Erholung nach Talfahrt | Trotz Jahresverlust von 12% halten Experten an Kaufempfehlungen für den Medizintechnik-Konzern fest. Hohe Bewertungskennzahlen sorgen jedoch für Skepsis. Die Stryker-Aktie zeigt heute erste Anzeichen... ► Artikel lesen | |
REGENERON PHARMACEUTICALS | 493,10 | -0,40 % | Regeneron's SLBA For EYLEA HD Injection 8 Mg Gets Acceptance From FDA For Priority Review | WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN), Thursday announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License... ► Artikel lesen | |
EXACT SCIENCES | 37,210 | +1,83 % | Exact Sciences Corp.: New Data Highlight the Positive Impact of Exact Sciences' Oncotype DX Test on Patient Care and Healthcare Efficiency | Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced the presentation of new data further reinforcing the utility of its Oncotype DX Breast Recurrence Score... ► Artikel lesen | |
CSL | 135,20 | +0,75 % | Is the CSL share price a buy? Here's a top broker's view | ||
CANSINO BIOLOGICS | 3,190 | -2,68 % | CANSINOBIO (06185): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ... | ||
BEIGENE LTD ADR | 202,00 | -0,98 % | BEIGENE (06160): DATE OF FIRST QUARTER 2025 FINANCIAL RESULTS ANNOUNCEMENT AND NOTICE OF AUDIT COMMITTEE ACTION | ||
BIOMERIEUX | 113,50 | -0,35 % | BIOMERIEUX: bioMérieux - First-Quarter 2025 Business Review | ||
SINO BIOPHARM | 0,405 | -0,69 % | Kurs von Sino Biopharmaceutical steigt etwas (0,4449 €) | Am Aktienmarkt liegt die Aktie von Sino Biopharmaceutical derzeit im Plus. Zuletzt zahlten Investoren für das Papier 0,44 Euro. Eine Verteuerung in Höhe von 1 Cent erfreut derzeit die Aktionäre von... ► Artikel lesen | |
ZAI LAB LTD ADR | 26,000 | +2,36 % | ZAI LAB (09688): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | ||
CSTONE PHARMACEUTICALS | 0,272 | -2,16 % | CSTONE PHARMA-B (02616): (I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP | ||
CASI PHARMACEUTICALS | 2,040 | +1,49 % | CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company | BEIJING, CN / ACCESS Newswire / April 3, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative... ► Artikel lesen | |
3SBIO | 1,330 | 0,00 % | 3SBIO (01530): VOLUNTARY ANNOUNCEMENT 707 INJECTION (ANTI-VEGF/PD-1 BISPECIFIC ANTIBODY) GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA | ||
GENSCRIPT BIOTECH | 1,154 | 0,00 % | GENSCRIPT BIO (01548): (REVISED) NEXT DAY DISCLOSURE RETURNS |